A few years ago we could read articles claiming "Exoskeletons will one day replace wheelchairs". That the FDA regulates these kind of devices is a clear sign that they are about to enter the mass market.
Miniaturization of electronics, a steep drop in manufacturing costs of mechatronic parts, increased computational power, more powerful batteries. A number of recent technical developments converge into the realization of exoskeletons growing nearer and nearer.
In this rapidly expanding field, competitors are scrambling to put their new models onto the market.
In the beginning of 2015 FDA announced that power exoskeletons will be classified as Class II devices with Special Controls, which clarified the regulatory situation for these kinds of wearable devices. The special controls have been put in place to address a number of risk factors identified by FDA to be associated with the usage of powered exoskeletons.
For those used to medical device development, both the risks as well as the suggested requirements are straight forward. They include among other things, thermal and electric safety, biocompatibility and the obvious risk of falling to the ground.
To help exoskeleton manufacturers getting up and running with their documentation, we provided the Aligned Elements Exoskeleton Extension Package containing:
- 9 Potential Hazards (including mitigation strategies) outlined as exoskeleton associated risk factors by the FDA
- 38 exoskeleton Special Control Requirements deduced from 21 CFR Part 890 Docket No. FDA-2014-N-1903
This will give manufacturers a predefined starting point of setting up their Design History File with the intention of accelerating the documentation effort.
The Aligned Elements Exoskeleton Extension Package is downloadable here: Aligned Elements Exoskeleton Extension Package